Andera Partners
Key facts
Recent exits
Coverage notes
26 funds tracked, 305 portfolio companies (123 active · 182 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
305 companiesFunds & portfolio
Every fund Andera Partners has raised, with its portfolio companies. Hand-checked from public filings.
Andera Expansion IVGrowth2026 · 0yr€430M0 active
No portfolio companies tracked yet.
Andera Croissance 2Growth2025 · 1yr1 active
Andera MidCap 6Buyout2025 · 1yr3 active
Unrealized
3 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| MedTech | 2025 | ||
| Business Services | 2025 | ||
| TMT | 2025 |
BioDiscovery 7VC2025 · 1yr€500M8 active
Unrealized
8 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech | 2025 | ||
| Biotech | 2026 | ||
| – | – | 2026 | |
| Biotech | 2025 | ||
| Biotech | 2025 | ||
| MedTech | 2026 | ||
| MedTech | 2026 | ||
| TMT | 2025 |
Acto VMezzanine2024 · 2yr€1.1B7 active
Unrealized
7 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Logistics | 2025 | ||
| TMT | 2026 | ||
| Industrials | 2024 | ||
| Education | 2024 | ||
| Healthcare | 2025 | ||
| Business Services | 2025 | ||
| Business Services | 2025 |
Terra NeaInfrastructure2023 · 3yr€45M4 active
Unrealized
4 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| ClimateTech | 2025 | ||
| Industrials | 2024 | ||
| ClimateTech | 2023 | ||
| ClimateTech | 2024 |
Andera Smart Infra 1Infrastructure2022 · 4yr€233M9 active · 1 realized
Unrealized
9 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| ClimateTech | 2024 | ||
| Logistics | 2024 | ||
| ClimateTech | 2022 | ||
| ClimateTech | 2022 | ||
| ClimateTech | 2023 | ||
| ClimateTech | 2022 | ||
| ClimateTech | 2024 | ||
| ClimateTech | 2022 | ||
| ClimateTech | 2021 |
Realized
1 exit| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| ClimateTech | 2023 | 2026 | Trade Sale | – |
BioDiscovery 6VC2022 · 4yr€456M11 active · 3 realized
Unrealized
11 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech | 2023 | ||
| Biotech | 2023 | ||
| MedTech | 2023 | ||
| Biotech | 2023 | ||
| MedTech | 2023 | ||
| Biotech | 2024 | ||
| MedTech | 2024 | ||
| Biotech | 2022 | ||
| Biotech | 2023 | ||
| Biotech | 2024 | ||
| Biotech | 2022 |
Realized
3 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Biotech | 2022 | 2025 | Trade Sale | – | |||
| MedTech | 2023 | 2025 | Trade Sale | – | |||
| Biotech | 2022 | 2026 | Trade Sale | – |
Andera Expansion 3GrowthHarvesting2021 · 5yr€250M10 active · 1 realized
Unrealized
10 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Industrials | 2024 | ||
| TMT | 2022 | ||
| Education | 2022 | ||
| Real Estate | 2021 | ||
| Business Services | 2023 | ||
| TMT | 2021 | ||
| Business Services | 2024 | ||
| Financials | 2021 | ||
| Consumer | 2024 | ||
| MedTech | 2021 |
Andera MidCap 5BuyoutHarvesting2021 · 5yr€750M12 active
Unrealized
12 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Real Estate | 2024 | ||
| Construction | 2022 | ||
| Energy | 2023 | ||
| Construction | 2021 | ||
| HR Tech | 2024 | ||
| Business Services | 2023 | ||
| Healthcare | 2022 | ||
| TMT | 2022 | ||
| Education | 2021 | ||
| MedTech | 2021 | ||
| Industrials | 2024 | ||
| Telecom | 2022 |
Acto Mezzanine IVMezzanineHarvesting2020 · 6yr€500M21 active · 9 realized
Unrealized
21 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Financials | 2023 | ||
| Healthcare | 2022 | ||
| Education | 2023 | ||
| Business Services | 2023 | ||
| Business Services | 2022 | ||
| Education | 2021 | ||
| Business Services | 2021 | ||
| Consumer | 2023 | ||
| TMT | 2022 | ||
| Industrials | 2022 | ||
| Consumer | 2021 | ||
| Healthcare | 2023 | ||
| LegalTech | 2020 | ||
| Logistics | 2023 | ||
| TMT | 2023 | ||
| Hospitality | 2023 | ||
| Consumer | 2022 | ||
| Financials | 2023 | ||
| Telecom | 2021 | ||
| TMT | 2021 | ||
| Telecom | 2022 |
Realized
9 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Financials | 2022 | 2024 | Trade Sale | – | |||
| TMT | 2021 | 2022 | Trade Sale | – | |||
| TMT | 2020 | 2022 | Trade Sale | – | – | ||
| TMT | 2021 | 2023 | Trade Sale | – | |||
| Telecom | 2022 | 2025 | Trade Sale | – | |||
| TMT | 2020 | 2022 | Secondary | – | |||
| TMT | 2023 | 2024 | Trade Sale | – | |||
| TMT | 2020 | 2022 | Trade Sale | – | – | ||
| Financials | 2021 | 2022 | Trade Sale | – |
Cabestan CroissanceGrowthHarvesting2020 · 6yr€80M2 active · 2 realized
Unrealized
2 heldRealized
2 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Financials | 2020 | 2024 | Secondary | – | |||
| TMT | 2020 | 2022 | Trade Sale | – |
Winch Capital 4BuyoutHarvesting2018 · 8yr€445M6 active · 3 realized
Unrealized
6 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Financials | 2019 | ||
| Business Services | 2018 | ||
| Consumer | 2020 | ||
| TMT | 2019 | ||
| Real Estate | 2020 | ||
| Construction | 2019 |
Realized
3 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| HR Tech | 2019 | 2024 | Secondary | – | |||
| Energy | 2019 | 2025 | Secondary | – | |||
| Education | 2018 | 2021 | Trade Sale | – |
BioDiscovery 5VCRealized2017 · 9yr€345M15 active · 9 realized
Unrealized
15 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech | 2019 | ||
| Biotech | 2018 | ||
| Biotech | 2018 | ||
| Biotech | 2018 | ||
| Biotech | 2017 | ||
| Biotech | 2019 | ||
| Biotech | 2018 | ||
| Biotech | 2018 | ||
| MedTech | 2018 | ||
| Biotech | 2017 | ||
| MedTech | 2018 | ||
| MedTech | 2017 | ||
| MedTech | 2020 | ||
| Biotech | 2018 | ||
| MedTech | 2018 |
Realized
9 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Biotech | 2019 | 2026 | IPO | – | |||
| Biotech | 2021 | 2024 | Trade Sale | – | |||
| Biotech | 2019 | 2021 | Trade Sale | – | |||
| MedTech | 2018 | 2023 | Trade Sale | – | |||
| Biotech | 2017 | 2026 | IPO | – | |||
| Biotech | 2017 | – | Trade Sale | – | |||
| Biotech | 2018 | 2020 | Trade Sale | – | |||
| Biotech | 2021 | 2025 | IPO | – | |||
| Biotech | 2019 | 2021 | Trade Sale | – |
Acto Mezzanine IIIMezzanineRealized2017 · 9yr€315M3 active · 13 realized
Unrealized
3 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| TMT | 2019 | ||
| Business Services | 2019 | ||
| TMT | 2018 |
Realized
13 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Healthcare | 2018 | 2022 | Trade Sale | – | |||
| Healthcare | 2018 | 2021 | Recapitalization | – | – | ||
| Logistics | 2017 | 2022 | Trade Sale | – | – | ||
| Mobility | 2017 | – | Trade Sale | – | – | ||
| Real Estate | 2018 | 2021 | Recapitalization | – | – | ||
| TMT | 2019 | 2021 | Trade Sale | – | – | ||
| Telecom | 2019 | 2023 | Secondary | – | |||
| Healthcare | 2017 | – | Trade Sale | – | |||
| Business Services | 2018 | 2020 | Secondary | – | |||
| Energy | 2019 | 2022 | Trade Sale | – | |||
| AdTech | 2017 | 2021 | Trade Sale | – | |||
| Consumer | 2019 | 2022 | Trade Sale | – | – | ||
| TMT | 2019 | 2023 | Trade Sale | – |
Cabestan Capital 2GrowthRealized2016 · 10yr€170M4 active · 15 realized
Unrealized
4 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Business Services | 2019 | ||
| Real Estate | 2020 | ||
| HealthTech | 2019 | ||
| TMT | 2017 |
Realized
15 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| TMT | 2016 | 2022 | Secondary | – | |||
| Real Estate | 2017 | 2023 | Secondary | – | |||
| Business Services | 2019 | 2026 | Trade Sale | – | |||
| Consumer | 2018 | 2023 | Trade Sale | – | |||
| Real Estate | 2017 | 2023 | Trade Sale | – | |||
| MedTech | 2017 | – | Secondary | – | |||
| Business Services | 2016 | 2021 | Secondary | – | |||
| Mobility | 2017 | – | Trade Sale | – | – | ||
| Consumer | 2017 | – | Trade Sale | – | – | ||
| Business Services | 2017 | – | Trade Sale | – | – | ||
| Consumer | 2017 | 2019 | Secondary | – | |||
| HR Tech | 2016 | 2020 | Trade Sale | – | |||
| TMT | 2020 | 2024 | Secondary | – | |||
| Business Services | 2017 | 2022 | MBO | – | |||
| TMT | 2016 | 2023 | Trade Sale | – |
Winch Capital 3BuyoutRealized2015 · 11yr€300M2 active · 12 realized
Unrealized
2 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Telecom | 2017 | ||
| Consumer | 2017 |
Realized
12 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Telecom | 2015 | 2023 | Trade Sale | – | |||
| Consumer | 2016 | 2022 | Trade Sale | – | |||
| Construction | 2017 | 2019 | Trade Sale | – | |||
| TMT | 2015 | 2018 | Trade Sale | – | |||
| Consumer | 2017 | 2023 | Trade Sale | – | – | ||
| Construction | 2015 | 2019 | Trade Sale | – | – | ||
| Healthcare | 2017 | 2021 | Secondary | – | |||
| Industrials | 2016 | 2021 | Secondary | – | |||
| Hospitality | 2017 | 2023 | Trade Sale | – | |||
| Business Services | 2015 | 2019 | Secondary | – | |||
| Financials | 2016 | 2018 | Secondary | – | |||
| Logistics | 2016 | 2021 | Trade Sale | – |
Acto Mezzanine IIMezzanineRealized2014 · 12yr€209M0 active · 12 realized
Realized
12 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Logistics | 2014 | 2018 | Secondary | – | |||
| Financials | 2015 | 2019 | Trade Sale | – | |||
| Business Services | 2015 | – | Trade Sale | – | |||
| Industrials | 2014 | – | Trade Sale | – | – | ||
| MedTech | 2014 | 2020 | Trade Sale | – | |||
| Industrials | 2015 | – | Trade Sale | – | – | ||
| Mobility | 2016 | 2019 | MBO | – | |||
| Construction | 2016 | 2019 | Trade Sale | – | – | ||
| Hospitality | 2016 | 2019 | Trade Sale | – | – | ||
| Financials | 2015 | 2018 | Trade Sale | – | |||
| Telecom | 2014 | 2019 | Secondary | – | |||
| Telecom | 2016 | 2021 | MBO | – |
BioDiscovery 4VCRealized2013 · 13yr3 active · 9 realized
Unrealized
3 heldRealized
9 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| MedTech | 2015 | 2020 | Trade Sale | – | |||
| MedTech | 2014 | 2019 | IPO | – | |||
| Biotech | 2014 | 2016 | Trade Sale | – | |||
| Biotech | 2013 | 2017 | Trade Sale | – | |||
| Biotech | 2016 | 2021 | Trade Sale | – | – | ||
| Biotech | 2013 | 2014 | Trade Sale | – | |||
| Biotech | 2015 | 2022 | Trade Sale | – | |||
| Biotech | 2015 | 2021 | Trade Sale | – | |||
| Biotech | 2016 | 2017 | Trade Sale | – | – |
Winch Capital 2BuyoutRealized2012 · 14yr€250M0 active · 9 realized
Realized
9 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Real Estate | 2014 | 2022 | Trade Sale | – | |||
| Telecom | 2012 | – | Trade Sale | – | – | ||
| Industrials | 2014 | 2019 | Trade Sale | – | |||
| Telecom | 2013 | 2019 | Trade Sale | – | – | ||
| Consumer | 2014 | 2019 | Secondary | – | |||
| Business Services | 2013 | 2017 | Trade Sale | – | |||
| Logistics | 2013 | 2019 | MBO | – | |||
| Telecom | 2014 | 2016 | Trade Sale | – | |||
| Aerospace & Defence | 2013 | – | Trade Sale | – |
Cabestan Capital 1GrowthRealized2010 · 16yr0 active · 34 realized
Realized
34 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| TMT | 2014 | 2018 | Trade Sale | – | |||
| Financials | 2015 | 2017 | Trade Sale | – | |||
| Telecom | 2012 | – | Trade Sale | – | – | ||
| Business Services | 2010 | – | Trade Sale | – | – | ||
| Construction | 2011 | 2020 | Trade Sale | – | |||
| ClimateTech | 2009 | 2019 | Trade Sale | – | |||
| Industrials | 2011 | – | Trade Sale | – | |||
| Logistics | 2011 | 2019 | MBO | – | |||
| Consumer | 2011 | – | Trade Sale | – | – | ||
| Business Services | 2013 | 2018 | Trade Sale | – | |||
| Business Services | 2015 | 2019 | MBO | – | |||
| Business Services | 2014 | – | MBO | – | |||
| TMT | 2010 | 2015 | Secondary | – | |||
| Consumer | 2009 | – | Trade Sale | – | – | ||
| Industrials | 2015 | 2023 | Trade Sale | ||||
| Construction | 2010 | – | Trade Sale | – | – | ||
| Industrials | 2014 | 2018 | Secondary | – | |||
| Consumer | 2008 | – | Trade Sale | – | – | ||
| Construction | 2013 | – | Trade Sale | – | – | ||
| TMT | 2012 | 2017 | Trade Sale | – | |||
| Consumer | 2011 | – | Trade Sale | – | |||
| Consumer | 2011 | – | Trade Sale | – | |||
| Telecom | 2010 | – | Trade Sale | – | |||
| Logistics | 2012 | 2018 | Secondary | – | |||
| TMT | 2010 | – | Trade Sale | – | |||
| Industrials | 2015 | – | Trade Sale | – | |||
| Healthcare | 2012 | – | Trade Sale | – | – | ||
| E-commerce | 2012 | 2015 | Trade Sale | – | |||
| Telecom | 2013 | 2015 | Trade Sale | – | |||
| Financials | 2015 | 2018 | Secondary | – | |||
| TMT | 2013 | 2017 | Trade Sale | – | |||
| Construction | 2011 | 2019 | Secondary | – | |||
| TMT | 2010 | 2023 | Trade Sale | – | – | ||
| Construction | 2013 | 2022 | Trade Sale | – | – |
BioDiscovery 3VCRealized2009 · 17yr1 active · 9 realized
Realized
9 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| MedTech | 2011 | 2015 | IPO | – | – | ||
| Biotech | 2010 | 2014 | Trade Sale | – | |||
| MedTech | 2009 | 2013 | Trade Sale | – | |||
| Biotech | 2011 | 2014 | Trade Sale | – | – | ||
| Biotech | 2009 | 2015 | Trade Sale | – | |||
| MedTech | 2010 | – | Trade Sale | – | – | ||
| MedTech | 2011 | 2013 | Trade Sale | – | |||
| Biotech | 2009 | 2016 | Trade Sale | – | |||
| Biotech | 2009 | 2014 | IPO | – | – |
Winch Capital 1BuyoutRealized2008 · 18yr€166M0 active · 13 realized
Realized
13 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Business Services | 2011 | – | Trade Sale | – | |||
| Construction | 2007 | 2020 | Trade Sale | – | – | ||
| Industrials | 2011 | 2017 | Secondary | – | |||
| Real Estate | 2011 | 2017 | Secondary | – | |||
| Education | 2010 | – | Secondary | – | |||
| Real Estate | 2010 | 2021 | Trade Sale | – | |||
| Construction | 2010 | 2018 | Trade Sale | – | – | ||
| Consumer | 2010 | 2016 | Trade Sale | – | |||
| Aerospace & Defence | 2007 | 2019 | Trade Sale | – | – | ||
| Consumer | 2010 | – | Trade Sale | – | |||
| Consumer | 2011 | – | Trade Sale | – | – | ||
| Construction | 2011 | 2015 | Trade Sale | – | |||
| Logistics | 2010 | 2015 | Trade Sale | – | – |
BioDiscovery 2VCRealized2007 · 19yr1 active · 3 realized
Realized
3 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| MedTech | 2007 | 2013 | Trade Sale | – | – | ||
| Biotech | 2007 | 2016 | Trade Sale | – | – | ||
| MedTech | 2008 | 2019 | Trade Sale | – |
Acto Mezzanine IMezzanineRealized2007 · 19yr€187M0 active · 23 realized
Realized
23 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Construction | 2011 | – | Trade Sale | – | |||
| TMT | 2011 | – | Trade Sale | – | |||
| Construction | 2010 | – | Trade Sale | – | – | ||
| Pharma | 2007 | – | Trade Sale | – | |||
| Healthcare | 2011 | 2019 | Secondary | – | |||
| Industrials | 2011 | – | Trade Sale | – | – | ||
| Industrials | 2006 | – | Trade Sale | – | – | ||
| Industrials | 2013 | – | Trade Sale | – | – | ||
| Construction | 2010 | 2019 | Trade Sale | – | – | ||
| MedTech | 2007 | 2014 | Trade Sale | – | – | ||
| Industrials | 2013 | – | Trade Sale | – | – | ||
| MedTech | 2011 | 2016 | Trade Sale | – | |||
| Construction | 2007 | – | Trade Sale | – | – | ||
| Consumer | 2010 | 2019 | Trade Sale | – | – | ||
| Business Services | 2007 | – | Trade Sale | – | |||
| Consumer | 2009 | – | Trade Sale | – | – | ||
| Consumer | 2013 | 2019 | Trade Sale | – | |||
| Education | 2011 | – | Secondary | – | |||
| Industrials | 2008 | – | Trade Sale | – | – | ||
| Construction | 2008 | 2012 | Trade Sale | – | – | ||
| Mobility | 2008 | 2014 | Secondary | – | |||
| Logistics | 2007 | 2015 | Trade Sale | – | |||
| Logistics | 2008 | 2015 | Trade Sale | – |
BioDiscovery 1VCRealized2005 · 21yr0 active · 2 realized
Realized
2 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| MedTech | 2005 | 2012 | IPO | – | – | ||
| MedTech | 2005 | 2006 | Trade Sale | – | – |
Saved GPs appear in your watchlist, one click from your workspace.
About Andera Partners
Andera Partners is a European mid-market private equity firm with €5.3 billion of assets under management as of December 2024, headquartered in Paris with offices in Munich and Brussels. The firm became independent in 2017 through a management-led spinoff from Edmond de Rothschild Group, building on a multi-decade track record across the underlying investment teams. Andera operates as a multi-strategy platform spanning LBO, growth equity, small-cap, mezzanine financing, energy transition infrastructure and life sciences venture.
Investment thesis
Andera deploys capital across six complementary strategies: Andera Acto (mid-cap LBO), Andera Croissance (growth equity), Andera Expansion (small-cap), Andera Mezzanine (debt-equity hybrid), Andera Smart Infra (energy transition infrastructure) and Andera Life Sciences (biotech venture and growth). Sector focus across the platform spans Healthcare (particularly biotech and HealthTech), TMT, Industrials, Real Estate, Telecom and Consumer, with the Life Sciences franchise providing dedicated expertise in early and growth-stage biotech transactions across European and selectively North American targets.
Recent activity
Recent realised exits include AgoMab (healthcare, 2026), Avalyn Pharma (healthcare, 2026), Tubulis (healthcare, 2026), Artemys (TMT, 2025), Evommune (healthcare, 2025) and Imcheck (healthcare, 2025), reflecting strong 2026 distribution momentum across the Life Sciences franchise. The platform tracks 26 funds, 119 active portfolio companies and 181 realised exits across multiple strategy types and vintages. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
Get the full picture on Andera Partners.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in